论文部分内容阅读
本文报导应用正常产妇的胎盘组织来制备转移因子(TF),制备方法见《江苏医药》5(5):58,1979。TF的临床应用:一般对慢性病采用每周皮下注射1单位,10～12单位为一疗程。一、恶性肿瘤:对8例恶性肿瘤(纵隔恶性淋巴瘤、腹型恶性淋巴瘤、回肠恶性淋巴瘤、乳癌各一例,肺癌、食管癌各二例)患者经TF治疗后,6例食欲增加,睡眠好转,体力有所恢复,并经一年随访,病情没有恶化;治疗前植物血凝素皮试阴性,治疗后4例转阳,说明细胞免疫功能有所增强。
This article reports the use of normal maternal placental tissue to prepare transfer factor (TF) preparation methods, see “Jiangsu Medical” 5 (5): 58,1979. Clinical application of TF: The general use of chronic subcutaneous injection of 1 unit per week, 10 to 12 units for a course of treatment. First, the malignant tumor: Eight cases of malignant tumors (mediastinal lymphoma, abdominal malignant lymphoma, ileal malignant lymphoma, a case of breast cancer, lung cancer, two cases of esophageal cancer) after treatment by TF, 6 patients increased appetite, Better sleep, physical recovery, and after a year of follow-up, the disease did not deteriorate; before treatment hemagglutinin skin test negative, after treatment, 4 cases of positive, indicating that cellular immune function has been enhanced.